Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03081910
Title Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen (MAGENTA)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

mature T-cell and NK-cell lymphoma

anaplastic large cell lymphoma

T-cell acute lymphoblastic leukemia

mycosis fungoides

prolymphocytic leukemia

adult T-cell leukemia

T-cell lymphoblastic leukemia/lymphoma

peripheral T-cell lymphoma

Sezary's disease

non-Hodgkin lymphoma

angioimmunoblastic T-cell lymphoma

Therapies

CD5 CAR T cells

Cyclophosphamide + Fludarabine

Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.